BBC: AstraZeneca has updated the efficacy result of its coronavirus vaccine trial in the US after health officials questioned the figures.

This is the latest in a string of controversies surrounding the Oxford-AstraZeneca vaccine, over dosing, efficacy in the elderly, clots and supplies to the EU.

(S)afety officials monitoring the trial said (AstraZeneca used) "outdated information" that provided an "incomplete view of the efficacy data"

AstraZeneca is saying 'Well, we only fabricated the data a little bit', and that was just because 'we were in a rush'.